1. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
   Lin Long et al, 2024, Frontiers in Oncology CrossRef
2. The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles
   Chiara Ciardiello et al, 2018, Stem Cells International CrossRef
3. Reporter gene systems for the identification and characterization of cancer stem cells
   Nohemí Salinas-Jazmín et al, 2021, World Journal of Stem Cells CrossRef
4. Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
   Milica Nedeljković et al, 2019, Cells CrossRef
5. Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer
   Yasmin M. Attia et al, 2020, International Journal of Molecular Sciences CrossRef
6. Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis
   Fuyuki Sato et al, 2020, Clocks & Sleep CrossRef
7. 6-Methoxymellein Isolated from Carrot (Daucus carota L.) Targets Breast Cancer Stem Cells by Regulating NF-κB Signaling
   Ren Liu et al, 2020, Molecules CrossRef
8. Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
   Zeljko Todorovic et al, 2021, Nutrients CrossRef
9. CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
   Andrew Sulaiman et al, 2019, Cancers CrossRef
10. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma
    Heng-Wei Liu et al, 2019, Cancers CrossRef
11. Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
    Shujun Li et al, 2020, Frontiers in Genetics CrossRef
12. The Interleukin-6/Signal Transducer and Activator of Transcription-3/Cystathionine γ-Lyase Axis Deciphers the Transformation Between the Sensitive and Resistant Phenotypes of Breast Cancer Cells
    Zhaoyi Tan et al, 2021, Drug Metabolism and Disposition CrossRef
13. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
    Shinjit Mani et al, 2022, BioNanoScience CrossRef
14. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
    Martina Godel et al, 2020, International Journal of Molecular Sciences CrossRef
15. KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
    Mei Zhou et al, 2021, Breast Cancer Research and Treatment CrossRef
16. Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer
    Paul Holvoet, 2021, Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer CrossRef
17. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation
    Hardeep Singh Tuli et al, 2022, Molecular Biology Reports CrossRef
18. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer
    Alexandria DeCarlo et al, 2021, Bioconjugate Chemistry CrossRef
19. The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC
    Lohit Khera et al, 2021, Life Science Alliance CrossRef
20. STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential
    Sarah Q. To et al, 2022, Cancers CrossRef
21. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
    Tamir Baram et al, 2021, Frontiers in Oncology CrossRef
22. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Oncology CrossRef
23. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
    Lin He et al, 2021, Cancers CrossRef
24. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin
    Xiaoqing Wan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef